baxters clinical trials

Message Topic Search Topic Options Post Reply Create New Topic Printable Version Translate Topic

       http://www.baxter.com/about_baxter/news_room/news_releases/2006/10-04-06-h5n1_trial.html

In addition, the preliminary results suggest that the vaccine is highly immunogenic and elicits functional antibodies to H5N1 even at the lowest dose level of 3.75�g. Importantly, preliminary analysis of serum samples obtained from the study subjects suggests both the neutralization of the pandemic virus contained in the vaccine and cross-neutralization against widely diverse strains of H5N1, including both Hongkong/156/97 and Indonesia/05/05.

Author	Message Topic Search Topic Options Post Reply Create New Topic Printable Version Translate Topic
Guests Members Profile Send Private Message Find Members Posts Add to Buddy List Guest Group	Post Options Post Reply Quote Guests Thanks(0) Quote Reply Topic: baxters clinical trials Posted: October 05 2006 at 9:08pm
	http://www.baxter.com/about_baxter/news_room/news_releases/2006/10-04-06-h5n1_trial.html In addition, the preliminary results suggest that the vaccine is highly immunogenic and elicits functional antibodies to H5N1 even at the lowest dose level of 3.75�g. Importantly, preliminary analysis of serum samples obtained from the study subjects suggests both the neutralization of the pandemic virus contained in the vaccine and cross-neutralization against widely diverse strains of H5N1, including both Hongkong/156/97 and Indonesia/05/05.